Jubilant Pharmova's Stock Soars, Outperforms Sector and Market Averages

Jubilant Pharmova, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 9th, the company's stock gained 6.57%, outperforming the sector by 2%. This positive trend has been consistent for the past 5 days, with the stock rising 6.93% in that period.

The stock has also hit a new 52-week high of Rs.977.55, indicating a strong upward momentum. This has caught the attention of MarketsMOJO, who have given a 'Buy' call for Jubilant Pharmova's stock.

In terms of moving averages, Jubilant Pharmova is trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This is a positive sign for investors, as it shows a sustained upward trend in the stock's performance.

In comparison to the overall market, Jubilant Pharmova has outperformed the Sensex by a significant margin. Its 1-day performance was 5.79% compared to the Sensex's 0.21%, and its 1-month performance was 17.20% compared to the Sensex's 2.07%.

With such strong performance and a 'Buy' call from MarketsMOJO, Jubilant Pharmova's stock is definitely one to watch in the pharmaceutical industry. Investors can expect continued growth and positive returns from this midcap company.